 Barclays PLC lowered its position in shares of Eidos Therapeutics Inc NASDAQ:EIDX by 17.7 during the fourth quarter, according to its most recent disclosure with the Securities Exchange Commission. The firm owned 26,357 shares of the companys stock after selling 5,671 shares during the period. Barclays PLC owned approximately 0.07 of Eidos Therapeutics worth ... 